Get started free
HR 2821 119th Congress · House

Streamlining Drug Approvals: FDA Modernization Act 3.0

Official title: FDA Modernization Act 3.0

What This Bill Does

The FDA Modernization Act 3.0 aims to update and streamline the drug approval process to make it faster and more efficient for new medications to reach the market.

This bill matters to ordinary Americans as it could lead to quicker access to innovative treatments and medications, potentially improving healthcare outcomes and reducing costs associated with delays in drug availability.

Who This Bill Affects

If passed, this bill could mean that patients may benefit from faster access to new drugs, which could improve health outcomes and reduce the time they wait for effective treatments.

See how this bill affects you — sign in for a personalized analysis

Latest Status

May 21, 2026

Ordered to be Reported by the Yeas and Nays: 44 - 0.

Data sourced from api.congress.gov. AI summaries by BillBoard.